NASDAQ Composite ended the session with Novavax rising 5.59% to $189.01 on Thursday, following the last session’s upward trend. NASDAQ Composite jumped 0.11% to $14,778.26, following the last session’s upward trend on what was a somewhat bullish trend exchanging session today.


Today’s last reported volume for Novavax is 2645390, 38% below its average volume of 4267080.

Novavax’s last close was $189.01, 43.01% below its 52-week high of $331.68.

The company’s growth estimates for the current quarter is a negative 1110% and positive 12.1% for the next.

Novavax’s Revenue

Year-on-year quarterly revenue growth grew by 13143.4%, now sitting on 919.45M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Novavax’s stock is considered to be overbought (>=80).

Novavax’s Stock Yearly Top and Bottom Value

Novavax’s stock is valued at $189.01 at 18:16 EST, way below its 52-week high of $331.68 and way above its 52-week low of $76.59.

Novavax’s Moving Average

Novavax’s value is under its 50-day moving average of $196.34 and below its 200-day moving average of $194.01.

More news about Novavax (NVAX).


Please enter your comment!
Please enter your name here